160 related articles for article (PubMed ID: 38147791)
1. Investigating neural dysfunction with abnormal protein deposition in Alzheimer's disease through magnetic resonance spectroscopic imaging, plasma biomarkers, and positron emission tomography.
Matsuoka K; Hirata K; Kokubo N; Maeda T; Tagai K; Endo H; Takahata K; Shinotoh H; Ono M; Seki C; Tatebe H; Kawamura K; Zhang MR; Shimada H; Tokuda T; Higuchi M; Takado Y
Neuroimage Clin; 2024; 41():103560. PubMed ID: 38147791
[TBL] [Abstract][Full Text] [Related]
2. Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.
Murray ME; Przybelski SA; Lesnick TG; Liesinger AM; Spychalla A; Zhang B; Gunter JL; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Jack CR; Dickson DW; Kantarci K
J Neurosci; 2014 Dec; 34(49):16247-55. PubMed ID: 25471565
[TBL] [Abstract][Full Text] [Related]
3. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
Bittner DM; Heinze HJ; Kaufmann J
J Alzheimers Dis; 2013; 36(1):155-63. PubMed ID: 23579327
[TBL] [Abstract][Full Text] [Related]
4. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
5.
Kara F; Joers JM; Deelchand DK; Park YW; Przybelski SA; Lesnick TG; Senjem ML; Zeydan B; Knopman DS; Lowe VJ; Vemuri P; Mielke MM; Machulda MM; Jack CR; Petersen RC; Öz G; Kantarci K
Neurobiol Aging; 2022 Apr; 112():16-26. PubMed ID: 35038671
[TBL] [Abstract][Full Text] [Related]
6. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
[TBL] [Abstract][Full Text] [Related]
7. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of
Lu J; Ju Z; Wang M; Sun X; Jia C; Li L; Bao W; Zhang H; Jiao F; Lin H; Yen TC; Cui R; Lan X; Zhao Q; Guan Y; Zuo C;
Eur Radiol; 2023 Jul; 33(7):4567-4579. PubMed ID: 37099173
[TBL] [Abstract][Full Text] [Related]
9. Imaging increased glutamate in children with Sturge-Weber syndrome: Association with epilepsy severity.
Juhász C; Hu J; Xuan Y; Chugani HT
Epilepsy Res; 2016 May; 122():66-72. PubMed ID: 26970949
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's pathology targets distinct memory networks in the ageing brain.
Maass A; Berron D; Harrison TM; Adams JN; La Joie R; Baker S; Mellinger T; Bell RK; Swinnerton K; Inglis B; Rabinovici GD; Düzel E; Jagust WJ
Brain; 2019 Aug; 142(8):2492-2509. PubMed ID: 31199481
[TBL] [Abstract][Full Text] [Related]
11. Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies.
Su L; Blamire AM; Watson R; He J; Hayes L; O'Brien JT
Transl Psychiatry; 2016 Aug; 6(8):e877. PubMed ID: 27576166
[TBL] [Abstract][Full Text] [Related]
12. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.
Bejanin A; Schonhaut DR; La Joie R; Kramer JH; Baker SL; Sosa N; Ayakta N; Cantwell A; Janabi M; Lauriola M; O'Neil JP; Gorno-Tempini ML; Miller ZA; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
Brain; 2017 Dec; 140(12):3286-3300. PubMed ID: 29053874
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal Fluid Amyloid Beta, Tau Levels, Apolipoprotein, and
Piersson AD; Mohamad M; Rajab F; Suppiah S
Acad Radiol; 2021 Oct; 28(10):1447-1463. PubMed ID: 32651050
[TBL] [Abstract][Full Text] [Related]
14. Brain Amyloid-β Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer's Disease.
Li WW; Shen YY; Tian DY; Bu XL; Zeng F; Liu YH; Chen Y; Yao XQ; Li HY; Chen DW; Zhou FY; Yang H; Li QM; Bao WQ; Guan YH; Zhou HD; Jin RB; Wang YJ
J Alzheimers Dis; 2019; 69(1):169-178. PubMed ID: 30958377
[TBL] [Abstract][Full Text] [Related]
15. Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment.
King-Robson J; Wilson H; Politis M;
J Alzheimers Dis; 2021; 82(2):541-560. PubMed ID: 34057079
[TBL] [Abstract][Full Text] [Related]
16. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P
Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812
[TBL] [Abstract][Full Text] [Related]
17. Metabotropic glutamate receptor 5 (mGluR5) is associated with neurodegeneration and amyloid deposition in Alzheimer's disease: A [
Wang J; He Y; Chen X; Huang L; Li J; You Z; Huang Q; Ren S; He K; Schibli R; Mu L; Guan Y; Guo Q; Zhao J; Xie F
Alzheimers Res Ther; 2024 Jan; 16(1):9. PubMed ID: 38217040
[TBL] [Abstract][Full Text] [Related]
18. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A
Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714
[TBL] [Abstract][Full Text] [Related]
19. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
20. Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease.
Illán-Gala I; Lleo A; Karydas A; Staffaroni AM; Zetterberg H; Sivasankaran R; Grinberg LT; Spina S; Kramer JH; Ramos EM; Coppola G; La Joie R; Rabinovici GD; Perry DC; Gorno-Tempini ML; Seeley WW; Miller BL; Rosen HJ; Blennow K; Boxer AL; Rojas JC
Neurology; 2021 Feb; 96(5):e671-e683. PubMed ID: 33199433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
